Hainan Cancer Hospital
Clinical trials sponsored by Hainan Cancer Hospital, explained in plain language.
-
New combo therapy targets hard-to-treat pancreatic cancer
Disease control Recruiting nowThis early-phase study tests a new combination therapy for advanced pancreatic cancer. It uses two types of immune cells—dendritic cells (DCs) and CAR-T cells—both designed to target a protein called Claudin18.2 found on tumors. The goal is to see if this approach is safe and can…
Phase: EARLY_PHASE1 • Sponsor: Hainan Cancer Hospital • Aim: Disease control
Last updated May 14, 2026 12:03 UTC
-
Immune cell duo takes on tough tumors in early trial
Disease control Recruiting nowThis early-phase study tests a combination of two immune cell therapies—targeted dendritic cells and CAR-T cells—in 10 adults with advanced solid cancers like stomach, colon, or pancreatic cancer. The goal is to see if the treatment is safe and can shrink tumors by helping the im…
Phase: EARLY_PHASE1 • Sponsor: Hainan Cancer Hospital • Aim: Disease control
Last updated May 13, 2026 15:58 UTC